SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-001812
Filing Date
2023-02-06
Accepted
2023-02-06 06:02:40
Documents
12
Period of Report
2023-02-03
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K maia-20230203.htm   iXBRL 8-K 52815
  Complete submission text file 0000950170-23-001812.txt   174230

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT maia-20230203.xsd EX-101.SCH 2496
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT maia-20230203_lab.xml EX-101.LAB 14018
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT maia-20230203_pre.xml EX-101.PRE 10305
6 EXTRACTED XBRL INSTANCE DOCUMENT maia-20230203_htm.xml XML 4913
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 23588249
SIC: 2834 Pharmaceutical Preparations